Managing the Cost of C.
difficile Infection with Novel Therapies:
Best Practices in Managed Care for Improved
Clinical and Economic Outcomes
A continuing medical
education activity sponsored by NAMCP and AAMCN
This webinar series will provide critical updates on the advances in
the management of C. Difficile Infection
These are archives of live webinars held between October 13, 2021 to
October 15, 2021
If you participated in any of the live webinars, you are not
eligible to claim credit from the archive of that webinar.
By clicking on each of the titles, you will be able to participate
in each part.
It is not required that you participate in all.
These activities are valid from November 1, 2021 to November 1, 2023
series is supported by an educational grant from
This activity is intended for healthcare professionals practicing in managed
Instructions for CME/NCPD: Complete the pre-test,
listen to the audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your internet
browser without completing the post test, you will have ONE more opportunity to
complete. A score of 70% must be achieved on the post test to receive continuing
education credits. If you do not pass the post test after two attempts, you will
not be eligible to try again. Once you complete the evaluation form and score
70% or higher on your post test, you will automatically be given your
The epidemiology and incidence of hospital- and community-acquired Clostridium
difficile infection (CDI) has changed over the past decade resulting in
increased cases of initial and recurrent infection. Up to 25% of patients with
an initial episode of CDI experience disease recurrence. Recurrent CDI is
particularly challenging to manage.
This webcast series will provide education on reducing the risk of recurrence,
patient-specific risk factors for recurrent CDI, recommended and emerging
treatments for recurrent CDI, and managed care considerations around the
prevention and management of rCDI.